RECOMPENSATION TIMEFRAME AND STABILITY IN TREATMENT- NAIVE HBV- RELATED DECOMPENSATED CIRRHOSIS

被引：0

作者：

He, Zhiying ^{[1
]}

Wang, Bingqiong ^{[1
]}

Wu, Xiaoning ^{[1
]}

Hu, Zhongjie ^{[2
]}

Zhang, Chunqing ^{[3
]}

Hao, Yanqin ^{[4
]}

Yang, Yongfeng ^{[5
]}

Huang, Yan ^{[6
]}

Rao, Wei, Sr. ^{[7
]}

Wang, Jing ^{[8
]}

Xia, Shuai ^{[1
]}

Zhou, Jialing ^{[1
]}

Ou, Xiaojuan ^{[1
]}

Jia, Jidong ^{[1
]}

You, Hong ^{[9
]}

机构：

[1] Capital Med Univ, Natl Clin Res Ctr Digest Dis, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China

[2] Capital Mecical Univ, Beijing Youan Hosp, Beijing, Peoples R China

[3] Shandong First Med Univ, Prov Hosp, Tai An, Shandong, Peoples R China

[4] Shanxi Med Univ, Hosp 1, Taiyuan, Peoples R China

[5] South East Univ, Sch Med, Hosp Nanjing 2, Nanjing, Peoples R China

[6] Cent South Univ, Xiangya Hosp, Dept Infect Dis, Changsha, Hunan, Peoples R China

[7] Qingdao Univ, Affiliated Hosp, Liver Dis Ctr, Div Hepatol, Qingdao, Peoples R China

[8] Inner Mongolia Univ Sci & Technol, Baotou, Peoples R China

[9] Capital Med Univ, Beijing Friendship Hosp, Liver Res Ctr, Beijing, Peoples R China

来源：

HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1383- C

引用

页码：S488 / S489

页数：2

共 50 条

[41] Entecavir for the treatment of patients with hepatitis B virus-related decompensated cirrhosis
Sadler, Matthew D.
Coffin, Carla S.
Lee, Samuel S.
EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (10) : 1363 - 1369
[42] Refining Treatment Decisions in HCV-Infected Patients with Decompensated Cirrhosis: Frequency and Predictors of Recompensation with Direct-Acting Antiviral (DAA) Therapy
Radhakrishnan, Kavita
Dodge, Jennifer L.
McKinney, Jeff
Catalli, Lisa
Straley, Stephanie
Price, Jennifer C.
Terrault, Norah
HEPATOLOGY, 2018, 68 : 712A - 712A
[43] The C-Reactive Protein/Albumin Ratio as a Predictor of Mortality in Patients with HBV-Related Decompensated Cirrhosis
Wang, Chun-Jiang
Wu, Jian-Ping
Zhou, Wu-Qiong
Mao, Wei-Lin
Huang, Hang-Bin
CLINICAL LABORATORY, 2019, 65 (08) : 1531 - 1537
[44] Efficacy and Safety of Tenofovir Amibufenamide and Tenofovir Alafenamide for First-Time HBV-Related Decompensated Cirrhosis
Rong, Xinxin
Yang, Guangde
Xu, Yuanyuan
Chen, He
Wang, Xia
Fu, Juanjuan
Li, Li
Pan, Xiucheng
JOURNAL OF VIRAL HEPATITIS, 2025, 32 (04)
[45] Hepatic and extrahepatic metabolic modulation in hbv-related decompensated cirrhosis and acute-on-chronic liver failure
Li, Zhi-Wei
Tu, Sheng
Yu, Xia
Wang, Yi-Jie
Gong, Kai
Yang, De-Xin
Yao, Jun-Jie
Ren, Hao-Tang
Wu, Da-Xian
Zhang, Zhe-Hua
Su, Xiao-Ling
Wang, Yu
Pan, Zhao-Yi
Zhao, Rui-Hong
Sheng, Ji-Fang
Qiu, Yun-Qing
Shi, Yu
Sun, Ze-Yu
VIRULENCE, 2024, 15 (01)
[46] Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
Zhou, Jing
Mao, WeiLin
Shen, LiangJun
Huang, HongGuang
MEDICINE, 2019, 98 (52)
[47] Peripheral Blood Lymphocyte-to-Monocyte Ratio Predicts Mortality in Patients with HBV-Related Decompensated Cirrhosis
Qi, XiaoTing
CLINICAL LABORATORY, 2019, 65 (1-2) : 139 - 145
[48] Peripheral blood monocytes from patients with HBV related decompensated liver cirrhosis can differentiate into functional hepatocytes
Yan, Li
Han, Ying
Wang, Jingbo
Liu, Jingmei
Hong, Liu
Fan, Daiming
AMERICAN JOURNAL OF HEMATOLOGY, 2007, 82 (11) : 949 - 954
[49] Blood Urea Nitrogen-To-Albumin Ratio is a Predictor of Poor Outcomes in HBV-Related Decompensated Cirrhosis
Shen, Jianjiang
Shan, Zhiming
CLINICAL LABORATORY, 2023, 69 (04) : 786 - 792
[50] The Effects of Bacterial Infection on HBV-Related Decompensated Cirrhosis with or without Acute-on-Chronic Liver Failure
Cao, Zhujun
Wang, Shijin
Liu, Yuhan
Lu, Xiaobo
Jiang, Shaowen
Tang, Weiliang
Xu, Yumin
Xiang, Xiaogang
Zeng, Bo
Mo, Ruidong
Chen, Lichang
Ren, Peipei
Zhou, Tianhui
Cai, Minghao
Wang Hui
Cai, Wei
Li, Hai
Xie, Qing
HEPATOLOGY, 2018, 68 : 1334A - 1335A

← 1 2 3 4 5 →